We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current NCNA market cap is 158.04M. The company's latest EPS is GBP -0.5245 and P/E is -5.72.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.45M | -5.71M | -8.81M | -8.65M | -8.36M |
| Net Income | -7.87M | -5.41M | -6.7M | -7.66M | -6.84M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -25.68M | -32.95M | -48.17M | -44.01M | -31.63M |
| Net Income | -21.41M | -30.68M | -40.53M | -32.02M | -27.63M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 48.75M | 41.26M | 33.97M | 27.81M | 24.8M |
| Total Liabilities | 17M | 13.88M | 12.19M | 12.92M | 14.67M |
| Total Equity | 31.75M | 27.38M | 21.77M | 14.89M | 10.13M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 70.27M | 107.79M | 77.47M | 58.25M | 27.81M |
| Total Liabilities | 6.75M | 8.56M | 11.93M | 19.75M | 12.92M |
| Total Equity | 63.52M | 99.23M | 65.55M | 38.5M | 14.89M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -10.34M | -16.19M | -26.36M | -26.44M | -5.88M |
| Investing | 163k | 186k | 2.84M | 2.89M | 43k |
| Financing | -41k | -74k | -10k | -53k | 1.39M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -23.83M | -21.62M | -23.82M | -23.16M | -26.44M |
| Investing | -145k | -1.31M | -3.56M | 120k | 2.89M |
| Financing | -47k | 61.8M | -98k | -161k | -53k |
| Market Cap | 158.04M |
| Price to Earnings Ratio | -5.72 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 9.17 |
| Price to Book Ratio | 10.62 |
| Dividend Yield | - |
| Shares Outstanding | 52.68M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 2.73 (51.12%) |
| Company Name | NuCana PLC |
| Address |
77/78 cannon street london EC4N 6AF |
| Website | https://www.nucana.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
